Sakar Healthcare Ltd (SAKAR) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Part of MojoOne Strategy

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sakar Healthcare

Venus Remedies

Kwality Pharma

NGL Fine Chem

Hester Bios

Beta Drugs Ltd

Ind-Swift Labs.

Amrutanjan Healt

Jagsonpal Pharma

Windlas Biotech

Indoco Remedies

Why is Sakar Healthcare Ltd ?

With a growth in Net Profit of 91.32%, the company declared Outstanding results in Mar 26

The company has declared positive results for the last 6 consecutive quarters
OPERATING PROFIT TO INTEREST(Q) Highest at 10.89 times
PBT LESS OI(Q) At Rs 17.89 cr has Grown at 195.21%
ROCE(HY) Highest at 12.54%

High Institutional Holdings at 24.27%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Sakar Healthcare should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sakar Healthcare for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sakar Healthcare

122.45%

2.45

49.92%

Sensex

-6.83%

-0.51

13.27%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

21.59%

EBIT Growth (5y)

25.53%

EBIT to Interest (avg)

4.33

Debt to EBITDA (avg)

2.13

Net Debt to Equity (avg)

0.17

Sales to Capital Employed (avg)

0.53

Tax Ratio

23.32%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

24.27%

ROCE (avg)

7.95%

ROE (avg)

7.85%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.54

EV to EBIT

40.88

EV to EBITDA

26.90

EV to Capital Employed

4.88

EV to Sales

7.36

PEG Ratio

0.83

Dividend Yield

ROCE (Latest)

11.95%

ROE (Latest)

9.39%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

38What is working for the Company

OPERATING PROFIT TO INTEREST(Q)

Highest at 10.89 times

PBT LESS OI(Q)

At Rs 17.89 cr has Grown at 195.21%

ROCE(HY)

Highest at 12.54%

NET SALES(Q)

At Rs 71.10 cr has Grown at 41.52%

DEBT-EQUITY RATIO(HY)

Lowest at 0.17 times

PBDIT(Q)

Highest at Rs 26.24 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 36.91%

PAT(Q)

Highest at Rs 11.02 cr.

EPS(Q)

Highest at Rs 4.95

-5What is not working for the Company

INTEREST(Q)

At Rs 2.41 cr has Grown at 35.39%

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.03 times

Loading Valuation Snapshot...

Here's what is working for Sakar Healthcare

Operating Profit to Interest - Quarterly

Highest at 10.89 times and Grown

each quarter in the last five quarters

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 17.89 cr has Grown at 195.21%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 11.02 cr has Grown at 91.3%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly

Highest at Rs 71.10 cr and Grown

each quarter in the last five quarters

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly

At Rs 71.10 cr has Grown at 41.52%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Highest at Rs 26.24 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly

Highest at 36.91%

in the last five quarters

MOJO Watch

Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 17.89 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 11.02 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 4.95

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly

Lowest at 0.17 times

in the last five half yearly periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Sakar Healthcare

Interest - Quarterly

At Rs 2.41 cr has Grown at 35.39%

Quarter on Quarter (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debtors Turnover Ratio- Half Yearly

Lowest at 5.03 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio